NIAID Banner Logo Image

HIV Citations List: May, 2020

Literature Citations

1. High Yield Production of Recombinant Cyanovirin-N (Antiviral Lectin) Exhibiting Significant anti-HIV Activity, From a Rationally Selected Escherichia coli Strain. Agarwal, R., J. Trivedi, and D. Mitra. Process Biochemistry, 2020. 93: p. 1-11. ISI[000531102600001].
[WOS]. HIV_05_2020.

2. Potential Tools for Eradicating HIV Reservoirs in the Brain: Development of Trojan Horse Prodrugs for the Inhibition of P-glycoprotein with anti-HIV-1 Activity. Agrawal, N., J. Rowe, J. Lan, Q.G. Yu, C.A. Hrycyna, and J. Chmielewski. Journal of Medicinal Chemistry, 2020. 63(5): p. 2131-2138. PMID[31505928]. PMCID[PMC7073916].
[PubMed]. HIV_05_2020.

3. Novel 1'-homo-N-2'-deoxy-alpha-nucleosides: Synthesis, Characterization and Biological Activity. Carnero, A., V. Martin-Nieves, Y.S. Sanghvi, O.O. Russel, L. Bassit, R.F. Schinazi, S. Fernandez, and M. Ferrero. Research Advances, 2020. 10(27): p. 15815-15824. ISI[000530721700019].
[WOS]. HIV_05_2020.

4. Lycopodium japonicum: A Comprehensive Review on Its Phytochemicals and Biological Activities. Chen, Y.G., Q. Yang, and Y. Zhang. Arabian Journal of Chemistry, 2020. 13(5): p. 5438-5450. ISI[000531826800009].
[WOS]. HIV_05_2020.

5. PSGL-1 Restricts HIV-1 Infectivity by Blocking Virus Particle Attachment to Target Cells. Fu, Y.J., S.J. He, A.A. Waheed, D. Dabbagh, Z. Zhou, B. Trinite, Z. Wang, J.S. Yu, D. Wang, F. Li, D.N. Levy, H. Shang, E.O. Freed, and Y.T. Wu. Proceedings of the National Academy of Sciences of the United States of America, 2020. 117(17): p. 9537-9545. PMID[32273392]. PMCID[PMC7196789].
[PubMed]. HIV_05_2020.

6. Comparison of Various Radioactive Payloads for a Human Monoclonal Antibody to Glycoprotein 41 for Elimination of HIV-Infected Cells. Garg, R., K. Mills, K.J.H. Allen, P. Causey, R.W. Perron, D. Gendron, S. Sanche, J.W. Berman, M.K. Gorny, and E. Dadachova. Nuclear Medicine and Biology, 2020. 2020(82-83): p. 80-88. PMID[32113033]. PMCID[PMC7195259].
[PubMed]. HIV_05_2020.

7. Structure-based Design of Highly Potent HIV-1 Protease Inhibitors Containing New Tricyclic Ring P2-Ligands: Design, Synthesis, Biological, and X-Ray Structural Studies. Ghosh, A.K., S. Kovela, H.L. Osswald, M. Amano, M. Aoki, J. Agniswamy, Y.F. Wang, I.T. Weber, and H. Mitsuya. Journal of Medicinal Chemistry, 2020. 63(9): p. 4867-4879. PMID[32348139].
[PubMed]. HIV_05_2020.

8. Fragment-Based Discovery of Sulfur-containing Diarylbenzopyrimidines as Novel Non-Nucleoside Reverse Transcriptase Inhibitors. Han, S., Y. Lei, C. Pannecouque, E. De Clercq, C.L. Zhuang, and F.E. Chen. Chinese Chemical Letters, 2020. 31(3): p. 764-768. ISI[000527915100032].
[WOS]. HIV_05_2020.

9. Molecular Hybridization-inspired Optimization of Diarylbenzopyrimidines as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors with Improved Activity against K103N and E138K Mutants and Pharmacokinetic Profiles. Han, S., Y. Sang, Y. Wu, Y. Tao, C. Pannecouque, E. De Clercq, C. Zhuang, and F.E. Chen. ACS Infectious Diseases, 2020. 6(5): p. 787-801. PMID[31599568].
[PubMed]. HIV_05_2020.

10. Microwave-assisted Synthesis, Molecular Docking and anti-HIV Activities of Some Drug-like Quinolone Derivatives. Jassem, A.M., A.M. Dhumad, F.A. Almashal, and J.M. Alshawi. Medicinal Chemistry Research, 2020. 29: p. 1067-1076. ISI[000529588300001].
[WOS]. HIV_05_2020.

11. Design of Biphenyl-substituted Diarylpyrimidines with a Cyanomethyl Linker as HIV-1 NNRTIs via a Molecular Hybridization Strategy. Lei, Y., S. Han, Y. Yang, C. Pannecouque, E. De Clercq, C.L. Zhuang, and F.E. Chen. Molecules, 2020. 25(5): 1050. PMID[32111013]. PMCID[PMC7179183].
[PubMed]. HIV_05_2020.

12. Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors. Li, G., N.A. Meanwell, M.R. Krystal, D.R. Langley, B.N. Naidu, P. Sivaprakasam, H. Lewis, K. Kish, J.A. Khan, A. Ng, G.L. Trainor, C. Cianci, I.B. Dicker, M.A. Walker, Z.Y. Lin, T. Protack, L. Discotto, S. Jenkins, S.W. Gerritz, and A. Pendri. Journal of Medicinal Chemistry, 2020. 63(5): p. 2620-2637. PMID[32081010].
[PubMed]. HIV_05_2020.

13. Anti-HIV Tigliane Diterpenoids from Reutealis trisperma. Lu, Y., Y.S. Huang, C.H. Chen, T. Akiyama, S.L. Morris-Natschke, Y.Y. Cheng, I.S. Chen, S.Z. Yang, D.F. Chen, and K.H. Lee. Phytochemistry, 2020. 174: 112360. PMID[32229336].
[PubMed]. HIV_05_2020.

14. Unveiling RNA-Binding Properties of Verapamil and Preparation of New Derivatives as Inhibitors of HIV-1 Tat-Tar Interaction (Vol 85, Pg 207, 2020). Martin, C., S. De Piccoli, M. Gaysinski, C. Becquart, S. Azoulay, A. Di Giorgio, and M. Duca. ChemPlusChem, 2020. 85: 207- 216. ISI[000527843600001].
[WOS]. HIV_05_2020.

15. Optimization of 5-Substituted Thiazolyl Ureas and 6-Substituted Imidazopyridines as Potential HIV-1 Latency Reversing Agents. Nguyen, W., J. Jacobson, K.E. Jarman, T.R. Blackmore, H.J. Sabroux, S.R. Lewin, D.F. Purcell, and B.E. Sleebs. European Journal of Medicinal Chemistry, 2020. 195: 112254. PMID[32251744].
[PubMed]. HIV_05_2020.

16. Dasatinib Protects Humanized Mice from Acute HIV-1 Infection. Salgado, M., J. Martinez-Picado, C. Galvez, S. Rodriguez-Mora, B. Rivaya, V. Urrea, E. Mateos, J. Alcami, and M. Coiras. Biochemical Pharmacology, 2020. 174: 113625. PMID[31476293].
[PubMed]. HIV_05_2020.

17. A Bifunctional Nucleoside Probe for the Inhibition of the Human Immunodeficiency Virus-Type 1 Reverse Transcriptase. Shaw, T.A., C.J. Ablenas, G.F. Desrochers, M.H. Powdrill, D.A. Bilodeau, J.F. Vincent-Rocan, M. Niu, A. Monette, A.J. Mouland, A.M. Beauchemin, and J.P. Pezacki. Bioconjugate Chemistry, 2020. 31(5): p. 1537-1544. PMID[32259429].
[PubMed]. HIV_05_2020.

18. Design, Synthesis, and Mechanism Study of Benzenesulfonamide-containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities. Sun, L., A. Dick, M.E. Meuser, T. Huang, W.A. Zalloum, C.H. Chen, S. Cherukupalli, S. Xu, X. Ding, P. Gao, D. Kang, E. De Clercq, C. Pannecouque, S. Cocklin, K.H. Lee, X. Liu, and P. Zhan. Journal of Medicinal Chemistry, 2020. 63(9): p. 4790-4810. PMID[32298111].
[PubMed]. HIV_05_2020.

19. Loss of Tetherin Antagonism by Nef Impairs SIV Replication During Acute Infection of Rhesus Macaques. Tavakoli-Tameh, A., S.K. Janaka, K. Zarbock, S. O'Connor, K. Crosno, S. Capuano, H. Uno, J.D. Lifson, and D.T. Evans. Plos Pathogens, 2020. 16(4): e1008487. PMID[32302364]. PMCID[PMC7190186].
[PubMed]. HIV_05_2020.

20. Synthesis and Biological Evaluation of New 1,2,3-triazolyl-pyrazolyl-quinoline Derivatives as Potential Antimicrobial Agents. Thakare, P.P., A.D. Shinde, A.P. Chavan, N.V. Nyayanit, V.D. Bobade, and P.C. Mhaske. ChemistrySelect, 2020. 5(15): p. 4722-4727. ISI[000528045700044].
[WOS]. HIV_05_2020.

21. Molecular Docking, Synthesis and anti-HIV-1 Protease Activity of Novel Chalcones. Turkovic, N., B. Ivkovic, J. Kotur-Stevuljevic, M. Tasic, B. Markovic, and Z. Vujic. Current Pharmaceutical Design, 2020. 26(8): p. 802-814. PMID[32013827].
[PubMed]. HIV_05_2020.

22. Design, Synthesis and in Vitro Evaluation of 2-Oxo-N-substituted phenyl-2H-chromene-3-carboxamide Derivatives as HIV Integrase Strand Transfer Inhibitors. Wadhwa, P., P. Jain, and H.R. Jadhav. Letters in Drug Design & Discovery, 2020. 17(4): p. 418-427. ISI[000529803700007].
[WOS]. HIV_05_2020.

23. HIV-1 Fusion Inhibitors Targeting the Membrane-proximal External Region of Env Spikes. Xiao, T., G. Frey, Q. Fu, C.L. Lavine, D.A. Scott, M.S. Seaman, J.J. Chou, and B. Chen. Nature Chemical Biology, 2020. 16(5): p. 529-537. PMID[32152540].
[PubMed]. HIV_05_2020.

24. Synthesis and Biological Activity of Triacetonamine. Yousif, M.N.M., H.A. Soliman, M.M. Said, N.A. Hassan, and F.M.E. Abdel-Megeid. Russian Journal of General Chemistry, 2020. 90(3): p. 460-469. ISI[000527644900020].
[WOS]. HIV_05_2020.

25. Synthesis and Evaluation of Potent Human Immunodeficiency Virus 1 Protease Inhibitors with Epimeric Isopropanol as Novel P1' Ligands. Zhu, M., L. Ma, B. Dong, G. Zhang, J. Wang, J. Zhou, S. Cen, and Y. Wang. Future Medicinal Chemistry, 2020. 12(9): p. 775-794. PMID[32125179].
[PubMed]. HIV_05_2020.

Patent Citations

26. Substituted 6-Azabenzimidazole Compounds as HPK1 Inhibitors and Their Preparation. Balan, G., M.J. Bartlett, J. Chandrasekhar, J.A. Codelli, J.H. Conway, J.L. Cosman, R.V. Kalla, Z.A. Kasun, M. Kim, S.H. Lee, J.R. Lo, J.A. Loyer-Drew, S.A. Mitchell, T.D. Perry, G.B. Phillips, P.J. Salvo, S. Swaminathan, J.J. Van Veldhuizen, S.C. Yeung, and J. Zablocki. Patent. 2020. 2019-US58932 2020092621: 696pp.
[Patent]. HIV_05_2020.

27. Substituted 6-Azabenzimidazole Compounds as HPK1 Inhibitors and Their Preparation. Balan, G., M.J. Bartlett, J. Chandrasekhar, J.A. Codelli, J.H. Conway, J.L. Cosman, R.V. Kalla, M. Kim, S.H. Lee, J.R. Lo, J.A. Loyer-Drew, S.A. Mitchell, T.D. Perry, G.B. Phillips, P.J. Salvo, J.J. Van Veldhuizen, S.C. Yeung, and J. Zablocki. Patent. 2020. 2019-US58813 2020092528: 441pp.
[Patent]. HIV_05_2020.

28. Indazolylquinazolinone Derivatives as Inhibitors of Human Immunodeficiency Virus Replication and Their Preparation.Bowsher, M.S., E.P. Gillis, C. Iwuagwu, B.N. Naidu, K.E. Parcella, M. Patel, and K.M. Peese. Patent. 2020. 2019-IB59450 2020095176: 150pp.
[Patent]. HIV_05_2020.

29. Indazolylquinazolinones as Inhibitors of Human Immunodeficiency Virus Replication and Their Preparation.Bowsher, M.S., E.P. Gillis, C. Iwuagwu, K.E. Parcella, M. Patel, and A.X. Wang. Patent. 2020. 2019-IB59018 2020084491: 171pp.
[Patent]. HIV_05_2020.

30. Indazolylquinazolinone Derivatives as Inhibitors of Human Immunodeficiency Virus Replication and Their Preparation.Bowsher, M.S., E.P. Gillis, C. Iwuagwu, K.E. Parcella, and K.M. Peese. Patent. 2020. 2019-IB59451 2020095177: 125pp.
[Patent]. HIV_05_2020.

31. Preparation of Quinazolinyl-indazole Derivatives and Their Use as Inhibitors of Human Immunodeficiency Virus Replication. Bowsher, M.S., E.P. Gillis, and K.E. Parcella. Patent. 2020. 2019-IB59238 2020089778: 98pp.
[Patent]. HIV_05_2020.

32. Preparation of Cyclic Nucleotides as Sting Agonists. Diller, D.J., A. Metzger, D.E. Kaelin, Jr., S. Paget, C.-Y. Huang, B.F. McGuinness, A.J. Hospital, and W.R. Solvibile, Jr. Patent. 2020. 2019-16662980 20200131209: 209pp.
[Patent]. HIV_05_2020.

33. Indazolylquinazolinones as Inhibitors of Human Immunodeficiency Virus Replication and Their Preparation.Gillis, E.P., B.N. Naidu, K.E. Parcella, and M. Patel. Patent. 2020. 2019-IB59004 2020084480: 118pp.
[Patent]. HIV_05_2020.

34. Indazolylquinazolinones as Inhibitors of Human Immunodeficiency Virus Replication and Their Preparation.Gillis, E.P., K.E. Parcella, M. Patel, and K.M. Peese. Patent. 2020. 2019-IB59020 2020084492: 277pp.
[Patent]. HIV_05_2020.

35. Preparation of Quinolinylimidazolyloxononylcarboxamide Derivatives and Analogs for Use as Histone Deacetylase Inhibitors. Yu, W., J.A. Kozlowski, D.J. Clausen, J. Liu, Y. Yu, M. Wang, and B. Li. Patent. 2020. 2019-US59582 2020096916: 258pp.
[Patent]. HIV_05_2020.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2020